You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Dow
Medtronic
Merck
McKinsey

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CARVEDILOL

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Carvedilol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000294 Effects of Carvedilol on Cocaine Use in Humans - 11 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 1998-09-01 The purpose of this study is to examine carvedilol effects in response to cocaine.
NCT00000294 Effects of Carvedilol on Cocaine Use in Humans - 11 Completed National Institute on Drug Abuse (NIDA) Phase 2 1998-09-01 The purpose of this study is to examine carvedilol effects in response to cocaine.
NCT00004854 The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure Completed National Center for Research Resources (NCRR) Phase 1 1969-12-31 We would like to see if using Carvedilol in adjunct with Ace inhibitors will increase ejection fraction of the heart under echo. All interpretation of data will be sent to Boston Children's Hospital to be reviewed, which is the primary research center in this study. There are 5 hospitals participating in this study. The population targeted are children with moderate heart failure and must be on Ace inhibitors at the time of enrollment. Our outcome after placing them on Carvedilol is to change their ejection fraction on echo. The patients will be seen every 1-2 weeks, while we will titrate their medication to a maintenance dose. Secondary outcome is to increase quality of life, exercise tolerance and decrease their symptom scores as noted on their questionnaires.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Carvedilol

Condition Name

Condition Name for Carvedilol
Intervention Trials
Hypertension 22
Heart Failure 18
Healthy 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Carvedilol
Intervention Trials
Hypertension 39
Heart Failure 35
Hypertension, Portal 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Carvedilol

Trials by Country

Trials by Country for Carvedilol
Location Trials
United States 384
Japan 36
China 22
Korea, Republic of 17
Canada 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Carvedilol
Location Trials
New York 20
Texas 18
California 16
Florida 15
Pennsylvania 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Carvedilol

Clinical Trial Phase

Clinical Trial Phase for Carvedilol
Clinical Trial Phase Trials
Phase 4 52
Phase 3 27
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Carvedilol
Clinical Trial Phase Trials
Completed 70
Recruiting 32
Not yet recruiting 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Carvedilol

Sponsor Name

Sponsor Name for Carvedilol
Sponsor Trials
GlaxoSmithKline 23
Institute of Liver and Biliary Sciences, India 6
National Institute on Drug Abuse (NIDA) 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Carvedilol
Sponsor Trials
Other 183
Industry 56
NIH 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKesson
Harvard Business School
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.